Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Approved by the FDA for type 2 diabetes and chronic weight management, tirzepatide (Mounjaro, Zepbound) is administered as a weekly subcutaneous injection
Rodbard HW, Rosenstock J, Canani LH, Deerochanawong C, Gumprecht J, Lindberg S, Lingvay I, Sndergaard AL, Treppendahl MB, Montanya E., PIONEER 2 Investigators
For example, 6.25 mg between 5 mg and 7.5 mg
Ongoing research is needed to find out why some people benefit more than others and how to optimize results for all
US$ 23.45
US$ 22.47
US$ 29.20
US$ 24.78
US$ 26.14
US$ 22.28
US$ 20.80
